In recent years, previously unknown functions have been conferred to the RAAS and have been explored in mechanistic studies and disease models. Implication of bone marrow stem/progenitor cells in the cardiovascular protective or detrimental effects of RAAS is a prominent advancement because of the translational significance. Selected members of RAAS are now known to modulate migration, proliferation, and mobilization of bone marrow cells in response to ischemic insult, which are sensitive indicators of vascular repair-relevant functions. In this Chapter, protocols for most frequently used, in vitro, ex vivo, and in vivo assays to explore the potential of RAAS members to stimulate vascular repair-relevant functions of bone marrow stem/progenitor cells of human and murine origin.
Jarajapu YP, Grant MB (2010) The promise of cell based therapies for diabetic complications: challenges and solutions. Circ Res 106(5):854–869CrossRefPubMedGoogle Scholar
Jarajapu YP, Caballero S, Verma A et al (2011) Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells. Invest Ophthalmol Vis Sci 52(8):5093–5104CrossRefPubMedPubMedCentralGoogle Scholar
Jarajapu YP, Bhatwadekar AD, Caballero S et al (2013) Activation of the ACE2/angiotensin-(1-7)/mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitor cells. Diabetes 62(4):1258–1269CrossRefPubMedPubMedCentralGoogle Scholar
Singh N, Vasam G, Pawar R et al (2014) Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes. J Sex Med 11(9):2153–2163CrossRefPubMedPubMedCentralGoogle Scholar
Jarajapu YP, Hazra S, Segal M et al (2014) Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms. PLoS One 9(4):e93965CrossRefPubMedPubMedCentralGoogle Scholar
Singh N, Joshi S, Guo L et al (2015) ACE2/Ang-(1-7)/mas axis stimulates vascular repair-relevant functions of CD34+ cells. Am J Physiol Heart Circ Physiol 309(10):H1687–H1707Google Scholar